Certican

Certican (Everolimus) is an oral medication used to prevent organ rejection after transplants. This immunosuppressant helps manage the body's immune response, ensuring transplant success.

Certican is primarily used to prevent organ rejection in patients who have undergone liver or kidney transplants. It works by suppressing the immune system's ability to attack the transplanted organ. Everolimus is often part of a broader treatment plan to ensure the body accepts the new organ.

Common effects of Certican may include headaches, diarrhea, and increased risk of infections. Some users also report fatigue and swelling in the limbs. These effects can vary widely among individuals.

Certican should be handled with care, especially by those with a history of infections or liver problems. Regular monitoring by a healthcare provider is recommended. Always follow the prescribed dosage and consult a professional before making any changes.

Certican may interact with certain medications, including those metabolized by the liver's CYP3A4 enzyme. It's important to inform your healthcare provider about all medications you are taking to avoid potential interactions. Alcohol consumption should also be discussed with a healthcare professional.